维普中文期刊产品整合服务
28篇 您的检索式:作者名="DIAMANT B"
    题名 作者 年代 出处 被引量
1Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R 2012EN2012,,3:6
2Placental lipidand glycogen content in human and experimental diabetes mellitus显示文摘Diamant Y Z Metzger B E Freinkel N 1982Am J Obstet Gynecol1982,144,:1
3Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R 2012EN2012,,3:1
4Pereutaneus absorption of pimecrolimus is not increaed in patients with moderate to severeatopic dermatitis when pimecrolimus cream 1% is applied under occlusion 显示文摘Diamant T Roland K Thomas B 2010Dermatology2010,22,11:1
5Size-dependent disaggregation of stable protein aggregates by the DnaK chaperone machinery显示文摘Diamant S Peres Ben-Zvi A Bukau B 2000J Biol Chem2000,275,21:1
6Coen- zyme Q0 in health and disease 显示文摘OVERVAD K DIAMANT B HOLM L 1999Eur J Clin Nutr1999,53,10:1
7Exenatide once weekly versus insulin glargine lbr type 2 diabetes(DURATION-3): 3-year results of an open-label randomised trial显示文摘Diamant M Van Gaal L Guerci B 2014Lancet Diabetes Endocrinol2014,2,6:1
8Electrophysiological phenotype in the LQTS mutations YlllC and R518X in the KC- NQ1 gene显示文摘Diamant U B Vahedi F Winbo A 2013J Appl Physiol ( 1985)2013,115,10:1
9Size-dependent disaggregation of stable protein aggregates by the DnaK chaperone machinery显示文摘Diamant S Ben-Zvi AP Bukau B 2000J Biol Chem2000,275,28:1
10Exenatide once weekly versus insulin glargine for type 2 diabetes(DURATION-3):3-year results of an open-label randomised trial显示文摘Diamant M Van Gaal L Guerci B 2014Lancet Diabetes Endocrinol2014,2,6:1
11Correlation between lac- tate levels and pH in discs of patients with lumbar rhizopathies 显示文摘Diamant B Karlsson J Naehemson A 1968Expcrientia1968,24,12:1
12Micreparticles and exosomes:impact on normal and complicated pregnancy显示文摘 Lok CAR Diamant M 2007Am J Reprod Immunol2007,58,8:1
13Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition 显示文摘Bunck MC Diamant M Eliasson B 2010Diabetes Care2010,33,8:1
14Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R 2012EN2012,,3:1
15Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1 This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).显示文摘Douglas A Drossman Brenda B Toner William E Whitehead Nicholas E Diamant Chris B Dalton Susan Duncan Shelagh Emmott Valerie Proffitt Donna Akman Karen Frusciante Terry Le Kim Meyer Barbara Bradshaw Kristi Mikula Carolyn B Morris Carlar J Blackman Yuming H 2003Gastroenterology2003,,1:1
16An analysis of rocky coastal eastern Mediterranean fish assemblages and a comparison with anadjacent small artificial reef 显示文摘DIAMANT A TUVIA A B BARANES A 1986Journal of Experimental Marine Biology and Ecology1986,30,3:1
17Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition显示文摘Bunck MC Diamant M Eliasson B 2010Diabetes Care2010,33,8:1
18Exenatide once weekly versus insulin glargine for type 2 diabetes ( DURATION-3 ) : 3- year results of an open-label randomisedtrial 显示文摘Diamant M Van Gaal L Guerci B 2014Lancet Diabetes Endocrinol2014,,:1
19Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition显示文摘Bunck MC Diamant M Eliasson B 2010Diabetes Care2010,33,8:1
20Exenatide af- fects circulating cardiovascular risk biomarkers independently of changes in body composition 显示文摘BUNCK MC DIAMANT M ELIASSON B 2010Diabetes Care2010,33,8:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费